The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Catlett, I. M.
Right arrow Articles by Bishop, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Catlett, I. M.
Right arrow Articles by Bishop, G. A.
Right arrowPubmed/NCBI databases
*Substance via MeSH
The Journal of Immunology, 1999, 163: 2378-2381.
Copyright © 1999 by The American Association of Immunologists

CUTTING EDGE

Cutting Edge: A Novel Mechanism for Rescue of B Cells from CD95/Fas-Mediated Apoptosis1

Ian M. Catlett* and Gail A. Bishop2,*,{dagger},{ddagger},§

Departments of * Microbiology and {dagger} Internal Medicine, and {ddagger} Graduate Program in Immunology, University of Iowa, and § Veterans Affairs Medical Center, Iowa City, IA 52242


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results and Discussion
 References
 
CD95-induced apoptosis contributes to the maintenance of homeostasis in both B and T lymphocyte-mediated immunity. B cells increase CD95 expression in response to activation signals and become susceptible to CD95-induced apoptosis. Protection from CD95-mediated death signals can be induced in mature B cells by signals delivered through the B cell Ag receptor. In this paper we demonstrate for the first time that rescue from apoptosis can occur independently of de novo protein synthesis. This rescue from apoptosis prevents activation of caspase 8, the apical caspase in the CD95 death pathway, and CD95-FADD (Fas-associated death domain containing protein) association does not occur normally. Thus B cell activation signals can biochemically modify proximal elements of the CD95 death pathway and regulate the sensitivity of cells to apoptosis induction at an early stage in programmed cell death.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results and Discussion
 References
 
Resting B cells constitutively express very low levels of CD95 and are not susceptible to CD95-mediated apoptosis induction. Ligation of CD40, by interaction with an activated T cell expressing CD154 (CD40L), causes up-regulation of CD95 expression on B cells and renders them susceptible to CD95-mediated apoptosis (1, 2). Anergic B cells are effectively deleted by CD95 engagement, whereas B cells that have not been tolerized can be protected from CD95-mediated apoptosis by B cell receptor (BCR)3 engagement (3, 4, 5, 6). Thus, CD95-mediated apoptosis can contribute to the deletion of autoreactive B cells and/or B cells activated by "bystander" interactions with T cells in an Ag nonspecific fashion.

Regulation of apoptosis is a tightly controlled process and has principally been attributed to the transcriptional regulation of various genes. The most notable are Fas-associated death domain-like IL-1-converting enzyme (FLICE)-inhibitory protein (FLIP) (7), Toso (8), and the Bcl family members (9). Overexpression of genes encoding Bcl-2 or Bcl-xL protects B cells from CD95-mediated apoptosis (10, 11). In addition, a previously reported BCR-mediated rescue requires 12–18 h to fully protect and requires de novo protein synthesis (3, 12). Additionally, in other cell types the TNF receptor-associated factors (TRAF) 1 and 2 and inhibitor of apoptosis (IAP) (13) are able to inhibit apoptosis induction by CD95 and TNF. Thus, the susceptibility of cells to apoptosis induction can be regulated by the expression of pro- or antiapoptotic proteins.

The first documented step in CD95-mediated apoptosis is the recruitment of the adapter molecule Fas-associated death domain containing protein (FADD) (14, 15) to CD95, which allows the association of the zymogen form of caspase 8 with the CD95-FADD complex (16). Following the formation of the death-inducing signaling complex (DISC), caspase 8 is cleaved to form an active protease (16). Caspase 8 is the apical protease in the CD95 and TNFR-induced death cascade and is required (17) and sufficient for apoptosis induction (18, 19). Caspase 8 then cleaves downstream caspases, leading ultimately to the demise of the cell (20).

The murine B cell line A20 is susceptible to CD95-mediated apoptosis and can be rescued by signaling through its surface BCR (4). This BCR-mediated rescue has been attributed to the up-regulation of Bcl family members and the lack of caspase 1 activity (4). In contrast, we report here that BCR-mediated rescue occurs independently of de novo protein synthesis and blocks activation of caspase 8 and caspase 3, the initiating and effector proteases respectively. Surprisingly, rescue blocked association of CD95 and FADD. These results show that early biochemical events following BCR ligation interact with proximal signaling components of the CD95 death cascade.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results and Discussion
 References
 
Cells

A20, a mature IgG2a+ murine B cell line derived from a lymphoma of a BALB/c mouse (21), was provided by Dr. David McKean (Mayo Medical Center, Rochester, MN). Cells were grown in RPMI 1640 supplemented with 10% FCS, 10 µM 2-ME, and antibiotics (BCM).

Antibodies

Goat or sheep anti-mouse IgM or IgG and F(ab')2 were purchased from Jackson ImmunoResearch Laboratories (West Grove, PA) and Sigma (Saint Louis, MO). Anti-CD95 (Jo2) was purchased from PharMingen (San Diego, CA). Anti-TNP, clone UC8–169, Syrian hamster IgG (an isotype control for anti-CD95) was obtained from the American Type Culture Collection (Manassas, VA). Goat anti-caspase 8 and rabbit anti-caspase 3 were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Ab to mouse FADD was kindly provided by Dr. Astar Winoto (University of California, Berkeley) (22).

Assay for apoptosis

Cells were stimulated with anti-CD95 mAb (100 ng/ml) to induce apoptosis or a combination of anti-CD95 and additional Abs (10 µg/ml). At various times the cells were harvested, fixed in 70% ethanol, and stored at -20°C until further analysis. The samples were washed with PBS and resuspended in 0.5 ml phosphate-citrate DNA extraction buffer for 5 min. Following removal from the DNA extraction buffer, the cells were resuspended in PBS containing 200 µg/ml RNase A and 40 µg/ml propidium iodide. DNA content of the cells was determined using a Becton Dickinson (San Jose, CA) FACScan benchtop flow cytometer. Cells containing less than 2 N DNA were counted as apoptotic. Cycloheximide (CHX) was purchased from Sigma and used at a final concentration of 10 µM. Cells were pretreated with CHX for 30 min before the addition of stimuli.

Caspase activity assay

Caspase 8 activity in cells was determined using a kit from Clontech (Palo Alto, CA) following the protocol supplied by the manufacturer. Cells were stimulated with anti-CD95 (1 µg/ml) or anti-CD95 plus anti-BCR or isotype control Abs at 10 µg/ml. The cells were lysed in the provided buffer supplemented with 50 µg/ml PMSF, 50 µg/ml aprotinin, 10 µg/ml pepstatin, and 10 µg/ml leupeptin. Cellular debris was removed by centrifugation. The lysates were then incubated with substrate for caspase 8 (IETD-AFC) or caspase 3 (DEVD-AFC) (Biomol Research Laboratories, Plymouth Meeting, PA) for 1 h at 37°C. The samples were read on a spectrofluorometer, set at 400 nm excitation and 505 nm emission wavelengths.

Caspase activity was also assessed by Western blotting for caspase 3 or caspase 8. Briefly, cells were stimulated for 2 h with anti-CD95 at 1 µg/ml with or without anti-BCR or isotype control Abs at 10 µg/ml. Cells were lysed in 1% Nonidet P-40 lysis buffer containing protease inhibitors. Samples containing lysates from equal cell numbers were loaded onto SDS-polyacrylamide gels. Western blotting was conducted as described in Hsing et al. (23). Anti-caspase 3 or anti-caspase 8 were diluted 1:200 for blotting. Secondary Abs, anti-rabbit-HRP or anti-goat-HRP, were diluted 1:4000.

Immunoprecipitation of CD95 was conducted essentially as described by Zhang and Winoto (22) except that in some samples anti-BCR Abs were included, as in the apoptosis assay. Blots were probed for FADD (66 ng/ml) and Fas (1 µg/ml).


   Results and Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results and Discussion
References
 
B cells can be rescued from CD95-induced apoptosis by signals delivered through the BCR (4), but the precise mechanism of this rescue is poorly understood. Fig. 1Go shows that A20 cells, when stimulated with agonistic anti-CD95 Abs, underwent apoptosis rapidly and nearly completely. However, simultaneous addition of anti-CD95 and anti-IgG F(ab')2 abrogated the induction of apoptosis. Similar results were obtained using either sheep or goat anti-BCR Abs. Binding of anti-CD95 to the cells was not changed by the addition of anti-IgG F(ab')2, as assessed by flow cytometry (data not shown); thus the block in apoptosis induction is not a result of the anti-IgG F(ab')2 interfering with binding of anti-CD95. The addition of anti-IgM F(ab')2, an isotype not expressed on A20, failed to modify CD95-induced apoptosis. To exclude the possible involvement of Fc receptors the experiments were performed with anti-IgG F(ab')2 fragments (Fig. 1Go).



View larger version (33K):
[in this window]
[in a new window]
  		FIGURE 1. BCR signals rescue A20 from CD95-mediated apoptosis, and rescue is independent of de novo protein synthesis. A, A20 cells were stimulated with anti-CD95 mAb or a combination of anti-CD95 and anti-BCR F(ab')2 fragments. Cells were harvested at times shown and DNA content was determined. Results are representative of three similar experiments. B, Cells were treated as above except with the addition of 10 µM CHX 30 min before the addition of Abs. The average and SE of three experiments are shown.

 
The susceptibility of cells to apoptosis has been attributed to the transcriptional regulation of genes encoding various pro- or antiapoptotic proteins. However, the BCR rescue signal was effective with simultaneous addition of the two Abs and occurred quite rapidly (Fig. 1Go), suggesting early biochemical regulation of the death pathway. To test the possibility that production of antiapoptotic proteins was involved, cells were incubated with 10 µM CHX for 30 min before and during the experiments to block de novo protein synthesis. The CHX concentration used was sufficient to inhibit 97% of protein synthesis during the course of the experiment as measured by [3H]leucine incorporation (data not shown). Fig. 1GoB demonstrates that the rescue obtained was essentially the same in the presence and absence of de novo protein synthesis. Similar results were obtained with emetine HCl or the RNA synthesis inhibitor actinomycin D (data not shown). This finding eliminates the possibility of up-regulation and synthesis of new antiapoptotic proteins such as Bcl-2 or FLIP as a possible mechanism for BCR-mediated blocking of CD95-induced death in these B cells. This finding also strongly suggests that signals from the BCR act directly on the CD95 apoptosis induction pathway.

The results in Fig. 1Go suggested that signaling per se was responsible for the observed rescue. Thus, to test when the cells were irreversibly committed to apoptosis, we stimulated cells with anti-CD95 and added anti-BCR simultaneously or at hourly intervals thereafter. The results shown in Fig. 2Go demonstrate that the effectiveness of rescue is dramatically decreased by delaying the addition of the anti-BCR Ab by as little as 1 h, and a delay of 2 h after anti-CD95 virtually abrogated rescue. These data indicate that those cells in a culture that will undergo apoptosis are virtually all irreversibly committed to do so within 2 h of the addition of anti-CD95.



View larger version (25K):
[in this window]
[in a new window]
  		FIGURE 2. Delayed addition of the rescue signal does not block apoptosis. Cells were treated with anti-CD95 or anti-CD95 and anti-BCR for 12 h. Additionally, some cultures received the rescuing Ab 1 or 2 h after the addition of the anti-CD95. The average and SE of three experiments are shown.

 
CD95-mediated apoptosis is initiated by the activation of caspase 8, which is a member of a class of proteases that are activated during apoptosis. Activation of a caspase occurs when the zymogen form of the protease is cleaved into two or more pieces and two domains of the cleaved protease, of ~10 and 20 kDa, associate and form an active enzyme (16). Caspase 8 is found in association with activated CD95 receptors and is required for CD95-mediated apoptosis (16, 17, 22). The processing sites for caspase 8 suggest that it is autocatalytically cleaved and activated, whereas caspase 3 processing sites suggest it is activated by caspase 8 or a related activity (24). We hypothesize that activation of caspase 8 in cells is an irreversible event in the induction of apoptosis, and predict that it should also be a regulated event. It follows then, that in cells destined to live, very little if any active caspase 8 would be tolerated.

The hypothesis that activation of caspase 8 is an irreversible event in the induction of apoptosis predicts that rescue of cells should require the early addition of the rescuing stimuli. The data presented in Fig. 2Go are consistent with this hypothesis. Indeed, activation of caspase 8 occurs very early in CD95-mediated apoptosis, as we have detected increases in caspase 8 and 3 activities as early as 30 min after addition of anti-CD95 (data not shown). Activation of caspase 3 was assessed because it is thought to be directly downstream of caspase 8 and is a major effector caspase (24). To determine the earliest step in the CD95 pathway that is blocked by BCR rescue, we measured caspase activity using two methods: a fluorogenic assay and western blotting for cleavage of caspase 8 or 3. Cells treated with an isotype control Ab or left untreated had low basal levels of caspase 8 or 3 activity (Fig. 3Go, A and B), but these activities were dramatically increased upon stimulation with agonistic anti-CD95 Ab. However, neither were activated in BCR-rescued cells. Treatment with isotype control Ab had no effect on caspase activity. Similar results were seen in the presence of CHX (data not shown), again demonstrating that BCR signaling rescues cells directly and not as a secondary event.



View larger version (23K):
[in this window]
[in a new window]
  		FIGURE 3. Activation of caspases 8 and 3 is blocked in BCR rescued cells. Cells were treated with stimuli for 90 min (A and B) or 2 h (C and D). A, Caspase 8 activity in cells was determined by a fluorogenic assay using IETD-AMC as the substrate. The average and SE of three experiments are shown. B, Caspase 3 activity was determined using a similar fluorogenic assay with DEVD-AMC as a substrate. The average and SE of three experiments are shown. Caspase 8 (C) and caspase 3 (D) activation was determined by Western blotting for the appearance of the active p20 subunit or the disappearance of the p32 zymogen respectively. Results are representative of three independent experiments.

 
Western blot analysis (Fig. 3Go, C and D) confirmed data acquired from the fluorogenic assay. Caspase 8 activity can be determined by blotting for the cleaved and active product of ~20 kDa. In resting cells no 20-kDa fragment was visible; however, upon stimulation through CD95 a 20-kDa band appeared. The band was greatly reduced when a BCR signal was delivered, whereas the isotype control, anti-IgM, had no effect. Similar experiments were performed using Ab to caspase 3, except that activation was assessed by the loss of the inactive 32-kDa zymogen. Cells stimulated with anti-CD95 lost the 32-kDa zymogen (Fig. 3GoD, compare lanes 1 and 2). However, cells that received BCR stimulation maintained their caspase 3 zymogen (lane 3). Isotype control Ab had no effect upon the loss of the 32-kDa band. Thus caspase 3 activation is consistent with the model that these proteins are in a proteolytic cascade initiated by caspase 8. These data show that the activation of the apical protease in CD95-mediated apoptosis, caspase 8, was blocked in BCR-rescued cells, as was the activity of the effector caspase, caspase 3. Our results are thus consistent with the hypothesis that caspase 8 activation is a tightly regulated event in CD95-mediated apoptosis.

The first step in CD95-mediated apoptosis is the recruitment of the adapter molecule FADD to the CD95 receptor (14, 15, 22). As CD95-FADD association precedes caspase 8 activation, the association of CD95 and FADD was assessed by immunoprecipitation experiments to determine whether BCR-induced decreases in caspase 8 activation reflect decreased recruitment of FADD. Fig. 4Go shows that FADD associates with CD95 when the cells have received signals through CD95 (lanes 1 and 2). In cells that have received BCR-derived rescue signals, the amount of associated FADD is greatly reduced (lanes 3 and 4). The Fas-FADD association was also blocked at 30 min (data not shown) and 90 min (lanes 5–8). Similar amounts of CD95 were precipitated as assessed by Western blotting. In experiments with F(ab')2 fragments that provided weaker protection some CD95-FADD association was seen reflecting the amount of apoptotic cells found in the cultures (data not shown). Neither CD95 nor FADD were precipitated with isotype control Ab (data not shown). The lower band in the FADD Western blot is thought to be a degradation product, which is only seen in precipitates of cells that are apoptotic (22). These data show that the earliest event in CD95-mediated apoptosis was blocked in the presence of rescue signals delivered through the BCR and that the second step, caspase 8 activation, was also blocked.



View larger version (69K):
[in this window]
[in a new window]
  		FIGURE 4. CD95:FADD association is blocked in rescued cells. Cells were stimulated for 10 or 90 min as indicated and CD95 was immunoprecipitated as described by Zhang and Winoto (22 ). F(ab')2 were added to the indicated samples to rescue. F(ab')2 were used as in Fig. 1Go. Blots were probed for FADD and CD95. Results are representative of nine independent experiments.

 
Apoptosis can be characterized as either intrinsic or extrinsic. Apoptosis resulting from growth factor withdrawal or DNA damage is intrinsically induced death and is thought to involve delayed induction of caspase activity through unknown mechanisms. This process is controlled by transcriptional regulation of pro- and antiapoptotic proteins and posttranslational modification of cellular proteins (9, 25, 26). Alternatively, cells may also be susceptible to receptor-mediated apoptosis induction, a cell extrinsic apoptosis. Receptor-mediated apoptosis is characterized by the early activation of caspases and rapid apoptosis of the affected cells. The regulation of receptor-mediated apoptosis has been attributed to the transcriptional control of genes required for apoptosis induction such as Fas (1, 2), Fas ligand (27), caspase 8 (28), or genes whose products interfere with apoptosis induction such as Toso and FLIP (8, 29). Data presented here demonstrate an additional mechanism for the control of CD95-mediated apoptosis. Signals induced via a transmembrane receptor, the BCR, can override the death signal delivered by CD95, and this rescue is a direct effect on the cellular components involved in apoptosis induction. Because rescue does not involve the up-regulation of new antiapoptotic proteins, cell fate can be controlled in a very rapid fashion. In B cells this may aid in retention of useful cells while allowing the elimination of autoreactive cells due to down-regulation of signaling in anergic B cells.


   Acknowledgments
 
We thank Luis Ramirez for technical assistance and Dr. Astar Winoto for providing Ab to FADD.


   Footnotes
 
1 This work was supported by grants to G.A.B. from the National Institutes of Health (AI28847 and CA66570) and the Veterans Administration (Merit Review 383). Core support was provided by National Institutes of Health Grant DK25295 to the University of Iowa Diabetes and Endocrinology Research Center. Back

2 Address correspondence and reprint requests to Dr. Gail A. Bishop, 3-570 BSB, Department of Microbiology, University of Iowa, Iowa City, IA 52242. E-mail address: Back

3 Abbreviations used in this paper: BCR, B cell receptor; FADD, Fas-associated death domain containing protein; FLIP, FLICE inhibitory protein; CHX, cycloheximide; IETD-AMC, the tetrapeptide: isoleucine-glutamic acid-threonine-aspartic acid conjugated to amino methyl coumarin; DEVD-AMC, the tetrapeptide: aspartic acid-glutamic acid-valine-aspartic acid conjugated to amino methyl coumarin. Back

Received for publication April 13, 1999. Accepted for publication July 7, 1999.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results and Discussion
 References
 

  1. Garrone, P., E. M. Neidhardt, E. Garcia, L. Galibert, K. C. van Kooten, J. Banchereau. 1995. Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J. Exp. Med. 182:1265.[Abstract/Free Full Text]
  2. Schattner, E. J., K. B. Elkon, D. H. Yoo, J. Tumang, P. H. Krammer, M. K. Crow, S. M. Friedman. 1995. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. J. Exp. Med. 182:1557.[Abstract/Free Full Text]
  3. Rothstein, T. L., J. K. Wang, D. J. Panka, L. C. Foote, Z. Wang, B. Stanger, H. Cui, S. T. Ju, A. Marshak-Rothstein. 1995. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 374:163.[Medline]
  4. Bras, A., C. Martinez-A, E. Baixeras. 1997. B cell receptor cross-linking prevents Fas-induced cell death by inactivating the IL-1 ß-converting enzyme protease and regulating Bcl-2/Bcl-x expression. J. Immunol. 159:3168.[Abstract]
  5. Rathmell, J. C., M. P. Cooke, W. Y. Ho, J. Grein, S. E. Townsend, M. M. Davis, C. C. Goodnow. 1995. CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells. Nature 376:181.[Medline]
  6. Rathmell, J. C., S. E. Townsend, J. C. Xu, R. A. Flavell, C. C. Goodnow. 1996. Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell 87:319.[Medline]
  7. Irmler, M., M. Thome, M. Hahne, P. Schneider, K. Hofmann, V. Steiner, J. L. Bodmer, M. Schroter, K. Burns, C. Mattmann, et al 1997. Inhibition of death receptor signals by cellular FLIP. Nature 388:190.[Medline]
  8. Hitoshi, Y., J. Lorens, S. I. Kitada, J. Fisher, M. LaBarge, H. Z. Ring, U. Francke, J. C. Reed, S. Kinoshita, G. P. Nolan. 1998. Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells. Immunity 8:461.[Medline]
  9. Adams, J. M., S. Cory. 1998. The Bcl-2 protein family: arbiters of cell survival. Science 281:1322.[Abstract/Free Full Text]
  10. Schneider, T. J., D. Grillot, L. C. Foote, G. E. Nunez, T. L. Rothstein. 1997. Bcl-x protects primary B cells against Fas-mediated apoptosis. J. Immunol. 159:4834.[Abstract]
  11. Alam, M. K., S. Davison, N. Siddiqui, J. D. Norton, J. J. Murphy. 1997. Ectopic expression of Bcl-2, but not Bcl-xL rescues Ramos B cells from Fas-mediated apoptosis. Eur. J. Immunol. 27:3485.[Medline]
  12. Foote, L. C., T. J. Schneider, G. M. Fischer, J. K. Wang, B. Rasmussen, K. A. Campbell, D. H. Lynch, S. T. Ju, A. Marshak-Rothstein, T. L. Rothstein. 1996. Intracellular signaling for inducible antigen receptor-mediated Fas resistance in B cells. J. Immunol. 157:1878.[Abstract]
  13. Wang, C. Y., M. W. Mayo, R. G. Korneluk, D. V. Goeddel, Jr A. S. Baldwin. 1998. NF-{kappa}B antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281:1680.[Abstract/Free Full Text]
  14. Chinnaiyan, A. M., C. G. Tepper, M. F. Seldin, K. O’Rourke, F. C. Kischkel, S. Hellbardt, P. H. Krammer, M. E. Peter, V. M. Dixit. 1996. FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J. Biol. Chem. 271:4961.[Abstract/Free Full Text]
  15. Kischkel, F. C., S. Hellbardt, I. Behrmann, M. Germer, M. Pawlita, P. H. Krammer, M. E. Peter. 1995. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 14:5579.[Medline]
  16. Muzio, M., A. M. Chinnaiyan, F. C. Kischkel, K. O’Rourke, A. Shevchenko, J. Ni, C. Scaffidi, J. D. Bretz, M. Zhang, R. Gentz, et al 1996. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death–inducing signaling complex. Cell 85:817.[Medline]
  17. Varfolomeev, E. E., M. Schuchmann, V. Luria, N. Chiannilkulchai, J. S. Beckmann, I. L. Mett, D. Rebrikov, V. M. Brodianski, O. C. Kemper, O. Kollet, et al 1998. Targeted disruption of the mouse caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity 9:267.[Medline]
  18. Martin, D. A., R. M. Siegel, L. Zheng, M. J. Lenardo. 1998. Membrane oligomerization and cleavage activates the caspase-8 (FLICE/MACH{alpha}1) death signal. J. Biol. Chem. 273:4345.[Abstract/Free Full Text]
  19. Memon, S. A., J. Hou, M. B. Moreno, C. M. Zacharchuk. 1998. Apoptosis induced by a chimeric Fas/FLICE receptor: lack of requirement for Fas- or FADD-binding proteins. J. Immunol. 160:2046.[Abstract/Free Full Text]
  20. Nicholson, D. W., N. A. Thornberry. 1997. Caspases: killer proteases. Trends Biochem. Sci. 22:299.[Medline]
  21. Kim, K. J., C. Kanellopoulos-Langevin, R. M. Merwin, D. H. Sachs, R. Asofsky. 1979. Establishment and characterization of BALB/c lymphoma lines with B cell properties. J. Immunol. 122:549.[Abstract/Free Full Text]
  22. Zhang, J., A. Winoto. 1996. A mouse Fas-associated protein with homology to the human Mort1/FADD protein is essential for Fas-induced apoptosis. Mol. Cell. Biol. 16:2756.[Abstract]
  23. Hsing, Y., B. S. Hostager, G. A. Bishop. 1997. Characterization of CD40 signaling determinants regulating nuclear factor-{kappa}B activation in B lymphocytes. J. Immunol. 159:4898.[Abstract]
  24. Thornberry, N. A., T. A. Rano, E. P. Peterson, D. M. Rasper, T. Timkey, M. Garcia-Calvo, V. M. Houtzager, P. A. Nordstrom, S. Roy, J. P. Vaillancourt, et al 1997. A combinatorial approach defines specificities of members of the caspase family and granzyme B: functional relationships established for key mediators of apoptosis. J. Biol. Chem. 272:17907.[Abstract/Free Full Text]
  25. Bergmann, A., J. Agapite, K. McCall, H. Steller. 1998. The Drosophila gene hid is a direct molecular target of Ras-dependent survival signaling. Cell 95:331.[Medline]
  26. del Peso, L., M. Gonzalez-Garcia, C. Page, R. Herrera, G. Nunez. 1997. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278:687.[Abstract/Free Full Text]
  27. Nagata, S., P. Golstein. 1995. The Fas death factor. Science 267:1449.[Abstract/Free Full Text]
  28. Perera, L. P., T. A. Waldmann. 1998. Activation of human monocytes induces differential resistance to apoptosis with rapid down-regulation of caspase-8/FLICE. Proc. Natl. Acad. Sci. USA 95:14308.[Abstract/Free Full Text]
  29. Yeh, J. H., S. C. Hsu, S. H. Han, M. Z. Lai. 1998. Mitogen-activated protein kinase kinase antagonized Fas-associated death domain protein-mediated apoptosis by induced FLICE-inhibitory protein expression. J. Exp. Med. 188:1795.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 J. Immunol.Home page
T. O. Nashar and J. R. Drake
The Pathway of Antigen Uptake and Processing Dictates MHC Class II-Mediated B Cell Survival and Activation
J. Immunol., February 1, 2005; 174(3): 1306 - 1316.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
P. Xie, B. S. Hostager, and G. A. Bishop
Requirement for TRAF3 in Signaling by LMP1 But Not CD40 in B Lymphocytes
J. Exp. Med., March 1, 2004; 199(5): 661 - 671.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
C. C. Tomlinson and B. Damania
The K1 Protein of Kaposi's Sarcoma-Associated Herpesvirus Activates the Akt Signaling Pathway
J. Virol., February 15, 2004; 78(4): 1918 - 1927.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. R. Schram and T. L. Rothstein
NF-{kappa}B Is Required for Surface Ig-Induced Fas Resistance in B Cells
J. Immunol., March 15, 2003; 170(6): 3118 - 3124.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. L. Wurster, V. L. Rodgers, M. F. White, T. L. Rothstein, and M. J. Grusby
Interleukin-4-mediated Protection of Primary B Cells from Apoptosis through Stat6-dependent Up-regulation of Bcl-xL
J. Biol. Chem., July 19, 2002; 277(30): 27169 - 27175.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
I. M. Catlett, P. Xie, B. S. Hostager, and G. A. Bishop
Signaling Through MHC Class II Molecules Blocks CD95-Induced Apoptosis
J. Immunol., May 15, 2001; 166(10): 6019 - 6024.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Catlett, I. M.
Right arrow Articles by Bishop, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Catlett, I. M.
Right arrow Articles by Bishop, G. A.
Right arrowPubmed/NCBI databases
*Substance via MeSH

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS